Jyong Biotech MENS
NASDAQ MENS
$1.74 -0.15 (-7.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

Jyong Biotech (MENS) Retained Earnings (2024 - 2025)

Updated

Jyong Biotech (MENS) reported Retained Earnings of -$37.75 million for the quarter ended Dec 31, 2025, compared with -$33.08 million a year earlier.

Analysis

Jyong Biotech (MENS) Retained Earnings (2024 - 2025) Analysis & Trends

  • By year, Retained Earnings came in at -$33.08 million in the year ended Dec 31, 2024 and -$30.06 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Eli Lilly 1,147.74 Bn 1,116.33 Bn 19.71 Bn 31.89 Bn
2 Johnson & Johnson 636.22 Bn 556.08 Bn 17.30 Bn 168.36 Bn
3 AbbVie 502.73 Bn 475.84 Bn 12.70 Bn -17.33 Bn
4 Merck 357.93 Bn 312.30 Bn 12.21 Bn 63.27 Bn
5 Novartis Ag 301.67 Bn 265.66 Bn 11.24 Bn -
6 Astrazeneca 264.02 Bn 237.70 Bn 12.86 Bn 12.59 Bn
7 Amgen 239.31 Bn 194.70 Bn 7.24 Bn -22.28 Bn
8 Gilead Sciences 194.97 Bn 169.17 Bn 6.22 Bn 2.20 Bn
9 Pfizer 171.63 Bn 118.27 Bn 10.94 Bn 112.09 Bn
10 Jyong Biotech 128.13 Mn 128.13 Mn - -37.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -37.75 Mn
Jun 30, 2025 -34.33 Mn
Dec 31, 2024 -33.08 Mn
API Access

Jyong Biotech Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=MENS&period=max&api_key=YOUR_API_KEY